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Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating and
disabling disease which primarily affects individuals in their early life between 20 and
40 years of age. MS is a complex condition, which may lead to a variety of upper limb
(UL) dysfunctions and functional deficits.
Objective: To explore upper limb impairments at body function, activity, and
participation in persons with MS (PwMS) and severe hand dexterity impairment by
behavioral and surface electromyography (sEMG) assessments.
Methods: This observational cross-sectional study involved 41 PwMS with severe hand
dexterity impairment stratified according to the Expanded Disability Status Scale (EDSS)
into mild–moderate (n = 17; EDSS, 1–5.5), severe ambulant (n = 15; EDSS, 6–6.5), and
severe nonambulant (n= 9; EDSS, 7–9.5). Behavioral outcomemeasures exploring body
function, activity, and participation were administered. The sEMG activity of six upper limb
muscles of the most affected side was measured during a reaching task.
Results: The most severe group was significantly older and more affected by secondary
progressive MS than the other two groups. Positive significant associations between
UL deterioration and impairments at different International Classification of Functioning,
Disability, and Health domains were noted in the most severe group. The progressive
decline in manual dexterity was moderately to strongly associated with the deterioration
of the overall UL activity (ρ = 0.72; p < 0.001) and disuse (amount of use ρ = 0.71;
p < 0.001; quality of movement ρ = 0.77; p < 0.001). There was a low correlation
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between manual dexterity and UL function (ρ = 0.33; p = 0.03). The muscle activation
pattern investigated by sEMG was characterized by a decrease in modularity and timing
delay in the wrist extensor muscles activation in the severe ambulant patients (EDSS,
6–6.5). Similar impairments were observed in the proximal muscles (anterior deltoid) in
the more advanced stages (EDSS ≥ 7).
Conclusion: Behavioral assessment, together with measures of muscle activation
patterns, allows investigating the pathophysiology of UL impairments in PwMS
across progressive neurological disability severity to implement task-specific
rehabilitation interventions.
Keywords: upper limb abnormalities, quality of life, participation, electromyography, multiple sclerosis
INTRODUCTION
Multiple sclerosis (MS) is the most common non-traumatic
cause of neurological disability in young adults between 20
and 40 years old, affecting about 2–3 million people globally
(1, 2). A greater understanding of the underlying genetic and
environmental factors involved in the MS pathophysiology has
been reached, followed by early accurate diagnosis and extensive
therapeutic management toward more personalized medicine
(2). However, MS continues to be a challenging condition both
in the treatment and prevention of the disabling progression of
the disease, especially in the progressive forms (2).
Rehabilitation plays an integral part in the management of
people with multiple sclerosis (PwMS). In the last decade, special
attention has been paid on gait and balance disturbances, as
they have been considered to be one of the key determinants
of mobility limitations and disability (3). However, up to 66%
of these patients suffer from upper limb (UL) dysfunctions (4).
SinceMS typically affects multiple functional systems, a variety of
symptoms significantly impact on the patient’s ability to perform
activities of daily living and quality of life (QoL) (4). Common
manifestations include muscle weakness, tremor, sensory deficits,
and impaired motor control (2). Fatigue and pain further impair
motor and functional outcomes (2).
The pathophysiology of UL impairments in PwMS is complex
and only partially known. The bulk of the literature on this
topic suggests that sensorimotor dysfunctions are not the
only mechanism to explain UL disability (5). For instance,
cognitive impairments (i.e., attentional and memory deficits)
and UL disuse might further affect UL function with negative
consequences on activity and participation (6–11).
Two issues need to be addressed to improve knowledge
on the pathophysiology of UL impairments. First, specific UL
assessment protocols should be shared among clinicians and
researchers. Second, technology-aided assessments should be
integrated into the UL assessment to explore function from
a qualitative and quantitative point of view. An accurate UL
assessment is challenging due to the inherent variability of
UL movements and the multifaceted manifestation of UL
dysfunctions in PwMS. Of note, the standard neurological
disability assessment using the Expanded Disability Status Scale
(EDSS) is mainly focused on mobility and walking ability
(8). As highlighted in the recent overview by Lamers et al.
(8), UL dysfunction in PwMS should be investigated within
the International Classification of Functioning, Disability, and
Health (ICF) framework including outcome measures referring
to body structure and function, activity, and participation (8).
A consensus of diagnostic hand dexterity impairment criteria
using the Nine-Hole Peg Test (NHPT) has been reached. These
criteria should improve the accuracy of epidemiological studies
and allow to monitor sensorimotor function in PwMS (3, 12,
13). Of note, a specific altered pattern of hand movement
can reflect brain maladaptation (14). However, the relationship
between different levels of UL impairments deserves further
investigation (5, 12, 15).
The literature on the instrumental assessment of UL
dysfunctions in PwMS is scant. Constraints in the use of such
technology are the costs to acquire the technological devices,
the need for specific expertise to acquire and analyze data,
and the time requested to set up the instrumental paradigm.
Strengths are the possibility to use it during functional tasks
and activity. Scattered evidence in PwMS suggests that surface
electromyography (sEMG) has many advantages over other
neurophysiological investigations to study muscle activation
pattern including non-invasive assessment, the possibility to
describe muscle activation during a controlled and repeatable
functional task, and the affordable costs in the rehabilitation
setting. Preliminary studies on small samples have reported lower
modulation in sEMG activity of distal UL muscles in patients
with moderate impairment during reaching to grasp task (16). A
more recent study by Pellegrino et al. (17) suggested that both
kinematic and electromyographic parameters might represent
biomarkers to help clinicians in differentiating patients with
different levels of UL motor impairment from healthy subjects
(17). Noteworthy, no patients with severe UL impairments have
been investigated, and no correlation between clinical outcome
and sEMG data was performed.
To accomplish this goal, we explored UL impairments at
different levels of ICF by behavioral and sEMG assessment in a
cohort of PwMS affected by severe hand dexterity impairment
and different levels of neurological disability.
Knowledge gained from this study will provide new insights
into the progressive deterioration of UL function and activity
across the different disease stages, as a thorough investigation
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of the UL impairments at different ICF domains would show
that manual dexterity deficit may be associated with multiple
UL dysfunctions depending on the neurological disability.
Preliminary analysis of UL muscle activation may suggest
changing in the modularity and timing of UL muscle activation
during a reaching task as sEMG correlates of the UL decline in
PwMS (16). Our preliminary results would be a reference for
prospective longitudinal studies on a large cohort of patients to
study behavioral and muscle activation pattern deterioration in
the different stages of the illness identified by the EDSS.
METHODS
In this observational cross-sectional study, we used data provided
by a database created for a randomized controlled trial on
hand dexterity robot-assisted rehabilitation by Gandolfi et al.
(18). A total of 113 patients were screened at the UOC
Neurorehabilitation Unit (AOUI Verona) and the Multiple
Sclerosis Center, U.O. Neurologia dU (AUOI Verona) from
March 2014 to March 2017. Inclusion criteria were the following:
confirmed diagnosis of MS (19); age between 18 and 65 years,
EDSS score 1.5 < x < 8 (19); Mini-Mental State Evaluation
≥ 24/30 (20); Modified Ashworth Scale score evaluated at the
elbow, wrist, and fingers ≤2 (21); and NHPT score between 30
and 300 s (13). Exclusion criteria were the absence of relapses
or relapse-related treatments in the 3 months before the study,
and other neurological or orthopedic diseases interfering with
UL function. After being informed about the experimental nature
of the study, patients gave their informed written consent.
The study was carried out following the Helsinki Declaration,
approved by the local Ethics Committee (prog no. 230 CESC),
and registered at a clinical trial. Eligible patients were categorized
into three disability groups according to the EDSS: group 1,
mild–moderate (1.5–5.5); group 2, severe ambulant (6–6.5);
and group 3, severe non-ambulant (5). The EDSS was used
to categorize the different disease stage severity, as it is the
worldwide measure of neurological impairment in PwMS already
used in the literature (5).
ASSESSMENTS
A neurologist determined demographic and clinical data such
as gender, age, hand dominance determined by the Edinburg
Handedness Inventory (EHI) (22), disease duration (years),
type of MS, and the EDSS. According to the ICF, clinical
and instrumental assessments were administered by a research
therapist to explore body function, activity, and participation.
The ICF is the WHO framework for measuring health and
disability at the individual and population levels, taking into
account environmental and personal factors (23). The body
function domain refers to the physiological function of the body
system, including psychological functions. The activity domain
refers to the execution of a task or action by the individual.
The participation level describes the personal involvement in
real-life situations (23). Clinical assessments were carried out
by blinded assessors about the EDSS score cut points defining
the different study groups. A physiotherapist with experience in
the sEMG acquisition acquired instrumental assessments. Data
processing was carried out by external research collaborators not
involved in the data collection to limit possible performance and
detection bias.
Upper Limb Functions and Structures
The Fugl–Meyer–UL section (FM) was used as a measure of
UL function. FM includes evaluation of reflex activity, volitional
movement, and coordination of the UL (range of score, 0–
66; higher = better performance) (24). The Motricity Index
measured muscle strength at the shoulder, elbow, and pinch
grip (range of score, 0–100; higher = better performance) (25).
TheModified Ashworth Scale (MAS)measured resistance during
passive stretching of shoulder adductors, elbow, and wrist flexors
(range of score, 0–5; higher = worse performance) (21). A
total UL MAS score was also computed as the sum of shoulder
abductors, elbow, and wrist flexors single scores (21). Tremor
Severity Scales assessed the UL tremor across four domains: rest
tremor, postural tremor, kinetic tremor, and intention tremor
(range of score for each domain, 0–10; higher = more severe
tremor) (26). Numeric Rating Scale assessed fatigue. Patients
answered the question “Do you perceive fatigue during UL
activity?” (range of score, 0–10; higher= worse symptoms) (27).
Upper Limb Activity
The NHPT was used to evaluate manual dexterity by computing
the pegs per second (peg/s) rate. The NHPT has been reported
to be responsive to UL activity level worsening (12, 13, 28).
A previous study by Lamers et al. (15) suggested that the
scores below 0.27 pegs/s indicate a severe hand dexterity deficit
(15). The action research arm test (ARAT) measured functional
arm skills with 19 items categorized in four sections (grasp,
grip, pinch, and gross) (range of score, 0–57; higher = better
performance) (29). The motor activity log (MAL) assessed
changes in the amount and the quality of the arm use in
accomplishing 30 daily activities (range of score, 0–168; higher
= better performance) (30).
Participation Level
The Multiple Sclerosis Quality of Life-54 with the physical health
and mental health domains measured generic and MS-specific
domains of health-related QoL (range of score, 0–100; higher
= better performance) (31). The patient’s satisfaction with daily
activities or social roles was assessed using the Life Habits
Assessment–general short form (32).
Instrumental Assessment
The patients underwent one session (three trials/session) of
sEMG acquisition as follows. The sEMG amplitude domain
from six upper limb muscles of the more affected side (deltoid
scapular, deltoid clavicular, triceps brachii, biceps brachii, flexor
carpi radialis, and extensor carpi radialis) was measured using
pairs of self-adhesive surface electrodes. The sEMG signals from
trapezius inferior and pectoralis major along with data from the
inertial sensor fixed to the subjects’ hand were not considered
because of the low quality of the signals acquired. Disposable
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Ag–AgCl electrodes were placed according to the Surface
Electromyography for the Non-invasive Assessment of Muscles
guidelines with an interelectrode spacing of 0.02m. Before
electrode placement, the skin was shaved with a disposable,
single-use razor and cleaned with alcohol (33). Raw sEMG
signals were collected using BTS FREEEMG 300 wireless sEMG
sensors (BTS spa, Milan, Italy) at a sampling rate of 1,000Hz.
Raw sEMG signals were processed with a customized routine
developed in MATLAB environment (MathWorks, USA). The
raw sEMG signal was bandpass filtered at 20–450Hz and then
smoothed using a 20-ms root mean square algorithm to obtain
the envelope. Signals were recorded during a functional task
of reaching while grasping an object (ARAT grasp section;
Figure 1). Patients sat upright in a standard chair with a firm back
without armrests according to the ARAT standard procedures
(34). Patients were asked to keep the trunk in contact with
the back of the chair during testing. The UL was positioned in
pronated position on the table. The task consisted of grasping
and placing a 7.5-cm wooden cube on a shelf of standardized
height (37 cm) corresponding to the grasp item of the ARAT
testing. The task was divided into three phases by identifying
four temporal events (start, grasping the cube, placing the cube
on the shelf, returning to initial position). The task was repeated
three times with a resting time of 2min between trials, and
the signals were averaged and time normalized. Normative data
were collected on a convenient sample involving 10 healthy age-
matched controls undergoing one session (three trials/session)
of the same sEMG acquisition protocol. The sEMG paradigm is
illustrated in Figure 1.
DATA ANALYSIS
Results about the most affected UL were reported. Descriptive
statistics included median and first through third quartiles
(Q1; Q3) to describe the magnitude of UL impairments
on the different ICF domains in the whole group and the
different EDSS subgroups. Since the data were not normally
distributed (Shapiro–Wilk test), non-parametric tests were used
for inferential statistics. The Kruskal–Wallis H test (“one-way
ANOVA on ranks”) was used to determine statistically significant
differences between the three groups of the independent
variables. Post hoc between-group comparisons were performed
using the Mann–Whitney U test (corrected for multiple
comparisons using Tukey’s multiple comparisons test).
As manual dexterity was previously showed to play a key
role in the UL overall impairment, linear correlations between
the NHPT and other outcome measures were computed using
Spearman’s correlation in the all sample to explore the strength
of the relationship among outcome measures. Data distribution
did not allow to perform a linear regression model, and the
correlation strength was defined as very high (ρ > 0.9), high (ρ =
0.7–0.89), moderate (ρ = 0.5–0.69), low (ρ = 0.3–0.49), or very
low (ρ < 0.29) (35).
The sEMGdata were qualitatively and quantitatively analyzed.
The normalized mean sEMG envelope for healthy subjects
and each patients’ subgroup was used to display the muscle
activation patterns during the movement and reported in figures.
Moreover, the timing of maximal muscle activation for each
phase was calculated as a percentage of the relative movement
phase (1–100%) for each group. One-way ANOVA was used
to determine statistically significant differences among groups.
Post hoc between-group comparisons were performed using the
Mann–Whitney U-test. According to the functional involvement
of the six muscles during the reaching task, muscles were
coupled as follows: (1) deltoid clavicular and biceps brachii,
as shoulder flexors; (2) biceps and triceps brachii, as agonist
and antagonist actors during the elbow flexion; and (3) flexor
and extensor carpi radialis because involved in maintaining the
wrist in neutral position during the wooden cube displacement.
The mean difference between the timing of maximal muscle
activation for each couple of muscles in each subgroup of PwMS
patients was computed. No frequency domain data analysis was
performed. Statistical analysis was carried out with SPSS 20.0
(IBM SPSS Statistics for Windows, Version 20.0, Armonk, NY,
USA) and Stata/IC 15.1 for MAC (StataCorp, TX, USA).
RESULTS
Forty-one patients have been included and allocated to mild–
moderate (n = 17), severe ambulant (n = 15), and severe
non-ambulant (n = 9) groups. All patients were assisted by
family members and were living in their home. No patients
were institutionalized or community-dwelling PwMS. Significant
between-group differences in age (p = 0.05) and the type of MS
among groups were measured. The most severe group was older
than the other two groups. Moreover, the majority of patients
in the most severe group were affected by secondary progressive
MS. Table 1 reports demographic and clinical characteristics of
the sample.
Body Functions and Structures Level
A statistically significant difference was found in UL function
(FM scale), and muscle tone (MAS), and the fatigue perceived
were measured (Table 2) among groups. Post hoc comparisons
showed that participant in the severe non-ambulant group
(group 3) experienced significantly higher UL muscle tone than
the mild–moderate group (group 1) (p = 0.002). Fatigue was
significantly higher in the severe ambulant group (group 2) than
the mild–moderate group (group 1) (p= 0.008) and significantly
lower in the severe nonambulant group (group 3) than the severe
ambulant (p= 0.004).
Activity Level
Manual dexterity assessed with the NHPT differed significantly
among groups (Table 2). PwMS showed a progressive decrease
of peg/second rate and a progressive reduction in UL use
according to the neurological disability (Table 2). The severe
non-ambulant participants (group 3) experienced significantly
higher impairments than the mild–moderate group (group 1)
in the NHPT (p = 0.015) and MAL (p < 0.001). The NHPT
score was strongly correlated to ARAT (ρ = 0.721, p < 0.001),
MAL-AOM (ρ = 0.712, p< 0.001), and MAL-QOM (ρ = 0.769,
p < 0.001). Conversely, there was a low correlation between
FM and NHPT score. Within the ICF framework, outcome
measures belonging to the activity domain were moderate to very
strongly correlated with each other. The MAL score in the severe
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FIGURE 1 | The reaching task (ARAT grasp subscale). The movement was divided into three phases, as shown.
TABLE 1 | Demographic and clinical characteristic of the sample.
MS subgroups p-value
Group 1 Group 2 Group 3
Total
(n = 41)
Mild–moderate
EDSS (1–5.5)
(n = 17)
Severe ambulant
EDSS (6–6.5)
(n = 15)
Severe NA
EDSS (7–9.5)
(n = 9)
Gender (F/M) 25/16 12/5 7/8 6/3 0.35
Age (years) 50.88 ± 10.9 45.88 ± 11.98 54.07 ± 9.16 55 ± 8.35 0.05*
EDSS 6 (4.25–6.5) 4 (3.5–5.25) 6 (6–6.5) 7.5 (7-8) <0.001*
EDSS sensory 2 (0.5–2) 1 (0–2) 2 (2) 1.5 (0.5–2)
Hand dominance (R/L/A) 36/5/0 13/4/0 14/1/0 9/0/0 0.16
Disease duration (years) 14.20 ± 8.76 12.12 ± 9.5 14.60 ± 8.52 17.44 ± 6.23 0.29
Type of MS (PP/RP/RR/SP) 2/2/22/15 0/1/13/3 1/1/8/5 1/0/1/7/9 0.05*
Visual impairment (yes/no) 2/39 0/17 1/14 1/8 0.70
Data are presented as frequency mean ± SD or median (25th/75th percentiles).
F, female; M, male; EDSS, Expanded Disability Status Scale; NA, nonambulant; R, right; L, left; A, ambidextrous; MS,Multiple sclerosis; RR, relapsing remitting; SP, secondary progressive;
PP, primary progressive.
*Significant p-value.
ambulant participants (group 2) differed significantly from the
severe non-ambulant group (group 3) (p= 0.001). No significant
differences in the ARAT total score were measured. However,
the grip subsection score was statistically different among groups
(p = 0.01). Post hoc comparisons showed that the severe non-
ambulant group (group 3) performance was worse than the
mild–moderate group (group 1) (Table 2, Figure 2).
Participation Level
The patient’s satisfaction with daily activities or social roles
assessed by the Life Habits Assessment–general short form
differed significantly among groups (Table 2). Participants in the
mild–moderate group (group 1) reported significantly higher
satisfaction than the severe ambulant (group 2) (p = 0.001)
and severe non-ambulant (group 3) group (p < 0.001). Post hoc
comparisons are shown in Figure 2.
Instrumental Assessment Results
The mean sEMG envelope in healthy controls showed a
relevant activation of deltoid anterior between phases 2 and 3,
corresponding to the deltoid’s typical recruitment during the
shoulder flexion. The triceps brachii activity was almost absent
during the entire movement, while a slight activation of the
biceps brachii was recorded during phases 2 and 3. Although the
overall activation value for flexor carpi muscles was <0.02mV,
a modulation in its activity, associated with the activity of higher
intensity of extensor carpi activation, was found at about 30% and
70–80% of the movement. This coupled activation was consistent
with forearm muscles’ function of wrist stabilization during a
grasping task. In PwMS, a progressive decrease in the modularity
of muscle activation was reported in association with increasing
in neurological disability. This loss of modularity was especially
evident in the flexor and extensor carpi muscles, where the most
severe patients showed a constant (but low) muscle activation
(Figure 3).
The between-group analysis of the timing of maximal muscle
activation showed statistically significant differences in the
anterior deltoid in phase 3 (p = 0.034), which was during the
eccentric contraction of the muscle, and in the extensor carpi
muscles during phase 2 (p = 0.020), while subjects were holding
the cube (Table 3). The post hoc analysis showed that severe non-
ambulant patients reported a delayed maximal activation of the
deltoid anterior compared to other groups in the last movement
phase (p = 0.027; adjusted for multiple comparisons). Similarly,
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TABLE 2 | Median scores (25th /75th percentiles) of clinical variables and p values comparing the three groups.
MS subgroups
Group 1 Group 2 Group 3
Total
(n = 41)
Mild–moderate
EDSS (1–5.5) (n = 17)
Severe ambulant
EDSS (6–6.5) (n = 15)
Severe NA
EDSS (7–9.5) (n = 9)
p value
Body function and structures
Fugl–Meyer (0–66) 60 (43–64.5) 63 (56.5–65) 56 (42–64) 48 (36.5–61) 0.037*
Motricity Index (0–100) 85 (73–93) 92 (74–93.75) 83 (71–94.75) 73 (64.5–90.5) 0.179
- Pinch grip (0–33) 26 (22–33) 26 (26–33) 26 (24–29.5) 22 (22–26) 0.169
- Elbow flexor (0–33) 25 (25–33) 33 (25–33) 25 (22–33) 25 (25–33) 0.579
- Shoulder abductors (0–33) 25 (25–33) 33 (25–33) 25 (25–33) 25 (19–33) 0.125
Modified Ashworth Scale (0–15) 0 (0–1) 0 (0–0.5) 0 (0–2) 2 (0.5–3) 0.008*
- Elbow flexors (0–5) 0 (0–1) 0 (0–0) 0 (0–0.5) 1 (0–1) 0.004*
- Wrist flexors (0–5) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0.5) 0.056
- Finger flexors (0–5) 0 (0–0) 0 (0–0) 0 (0–0.5) 0 (0–1) 0.395
Tremor Severity scale (0–5) 0 (0–2) 0 (0–2) 0 (0–3) 0 (0–2.5) 0.689
Numeric Rating Scale fatigue 6 (5–8) 6 (5–7.5) 8 (7–9) 5 (5–7.5) 0.005*
Activity level
NHPT (pegs/sec) 0.23 (0.14–0.27) 0.26 (0.23–0.28) 0.18 (0.15–0.26) 0.07 (0.04–0.20) 0.027*
ARAT (0–57) 49 (39.59–53) 52 (48–53) 47 (34–52) 40 (16.5–52.5) 0.145
- Grasp (0–18) 18 (12–18) 18 (18) 15.5 (11.75–18) 13 (6–18) 0.054
- Grip (0–12) 10 (8–12) 12 (11–12) 10 (7.75–12) 8 (6–10.25) 0.01*
- Pinch (0–18) 13 (12–17.5) 15 (12.25–15.75) 13 (9.75–18) 12 (2–13) 0.660
- Gross (0–9) 9 (7–9) 9 (9) 9 (5.75–9) 8 (4–9) 0.052
MAL AoU 113.5 (76.25–132.75) 131 (115.5–147.5) 113 (92–132) 69.5 (27.25–82.75) 0.005*
MAL QoM 108.75 (86.125–126.75) 123 (110.5–130.5) 108.5 (100–119) 69 (24–80.5) 0.001*
Participation level
LifeH 11.85 (9.97–12.91) 12.7 (12.1–14.53) 11.56 (8.95–12.1) 10.4 (8.72–10.66) < 0.001*
MSQOL-54 102.17 (60.8–129.84) 127.93 (60.22–146.15) 65.64 (51.2–110.49) 103 (78.57–121.32) 0.160
Data are presented as median (25th/75th percentiles).
EDSS, Expanded Disability Status Scale; MS, multiple sclerosis; NA, non-ambulant; NHPT, Nine-Hole Peg Test; ARAT, action research arm test; MAL, motor activity log; MSQoL-54,
Multiple Sclerosis Quality of Life-54; LifeH, Life Habits assessment–general short form.
*Significant p-value.
extensor carpi muscles were activated with a significant delay
in the severe group compared with the mild–moderate patients
in phase 2 (p = 0.043; adjusted for multiple comparisons).
Interestingly, the difference of the maximal activation of extensor
carpi muscles between patients and healthy subjects during the
holding-cube phase was found to be significantly correlated to
the performance at the NHPT (ρ =−0.44; p= 0.038).
The comparison between the difference in the timing of
maximal activation between functionally coupledmuscles did not
show any significant difference between groups. However, during
phase 2, the maximum of proximal muscles activation (biceps
brachii and deltoid anterior) occurred almost simultaneously
in healthy controls and moderate and severe ambulant patients
(groups 1 and 2). Conversely, severe non-ambulant patients
(group 3) showed a remarkable decrease in the modularity
of biceps brachii, which resulted in a different sequence in
the timing of activation. Similarly, the difference in temporal
activation of the biceps and triceps brachii showed an opposite
behavior between the severe non-ambulant group and the other
two groups. More in detail, patients of group 3 activated
the triceps brachii more than other patients, and the lack of
modularity of biceps activity prevents the calculation of the
maximum of the envelope. Concerning the forearm muscles, the
differences between the timing of maximal activation between
the flexors and extensor muscles, both in phases 2 and 3, were
remarkably higher in all groups as compared to the healthy
controls (Figure 4).
DISCUSSION
The results of this observational cross-sectional study suggest
that manual dexterity might be already impaired in the mild–
moderate stages when the overall neurological disability is
low. Strong to moderate significant associations between UL
deterioration and impairments at different ICF levels were noted
in the most severe group. The progressive decline in manual
dexterity, as measured by the NHPT, was associated with the
deterioration of the overall UL activity (measured by ARAT)
and disuse. Weakness, sensory loss, and tremor seemed not to
be significant determinants of UL deterioration in our cohort.
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FIGURE 2 | Median scores of clinical variables comparing the three subgroups. *Significant p-value.
FIGURE 3 | Mean surface sEMG envelope of healthy subjects (Top) and patients (Bottom).
The sEMG assessment showed impairments in both modularity
and timing of activation of distal (extensor carpi) muscles in the
severe ambulant patients, while impairments in the timing of
activation in the proximal muscles (anterior deltoid) were found
in the more advanced stages (EDSS ≥ 7).
To the best of our knowledge, this study is the first one
exploring objectively and subjectively UL dysfunction at different
ICF levels using clinical and instrumental assessments. Strength
in the methodology includes the fact that all patients suffered
from severe manual dexterity impairment and that clinical
and instrumental assessments were combined to explore the
multifaceted nature of UL dysfunction. Limitations are the small
sample of patients with severe neurological impairments and
the lack of prospective longitudinal assessments. Concerning
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TABLE 3 | Mean (standard deviation) of timing maximal muscle activation.
Movement
phase
Healthy
subjects
MS subgroups p-value
Group 1 Group 2 Group 3
Mild–moderate Severe ambulant Severe NA
EDSS (1–5.5) EDSS (6–6.5) EDSS (7–9.5)
Anterior deltoid 1 72.5 (25.6) 71.3 (23.4) 84.6 (15.2) 65.5 (24.3) 0.58
2 81.4 (15.0) 66.5 (17.9) 78.6 (18.7) 82.8 (6.9) 0.14
3 2.7 (3.8) 6.2 (7.2) 5.8 (11.6) 23.5 (27.4) 0.034*
Biceps brachii 1 65.1 (22.5) 57.2 (22.6) 59.4 (25.4) 64.5 (24.0) 0.86
2 67.5 (31.2) 56.17 (38.0) 67.8 (29.9) 59.3 (28.9) 0.84
3 42.9 (29.5) 32.8 (22.6) 39.6 (20.2) 30.0 (32.7) 0.75
Triceps brachii 1 67.1 (17.3) 73.4 (20.0) 68.0 (21.9) 54.0 (30.2) 0.47
2 68.5 (9.5) 68.6 (26.5) 48.8 (35.2) 84.8 (15.6) 0.14
3 15.1 (13.3) 18.7 (26.6) 27.2 (32.8) 25.0 (25.7) 0.77
Flexor carpi 1 82.7 (15.8) 74.5 (21.4) 60.8 (24.7) 63.8 (16.0) 0.16
2 34.4 (34.9) 70.6 (37.3) 47.0 (43.7) 50.0 (38.5) 0.19
3 22.0 (13.3) 32.2 (31.7) 59.2 (45.3) 64.0 (45.6) 0.07
Extensor carpi 1 81.1 (21.6) 73.6 (29.3) 52.0 (23.0) 65.0 (23.6) 0.18
2 27.2 (15.3) 26.3 (24.6) 65.4 (34.8) 54.5 (43.2) 0.020*
3 41.5 (31.9) 29.0 (28.0) 15.4 (15.3) 50.3 (30.2) 0.19
Data are reported as movement phase percentage.
*Significant p-value.
previous literature, our data confirm positive associations
between manual dexterity and UL function and activity level and
further explore new associations for discussion.
According to the literature, manual dexterity impairment is
one of the major determinants of disability in PwMS since the
first stages of the illness (5, 15). Hand dexterity plays a crucial role
in everyday life activities and social participation, as it has been
reported to be associated with independence in activities of daily
living and UL use (36). The NHPT is recommended as a gold
standard to measure hand dexterity for its excellent psychometric
properties. However, caution should be taken when assessing
PwMS with low (EDSS < 3) or high disability (EDSS > 6) for
its floor and ceiling effects, respectively (37). We reported an
overall mean score of NHPT of 0.19 pegs/s ranging between 0.23
pegs/s of the mild–moderate group to 0.12 pegs/s of the severe
non-ambulant group, which is below the cutoff values previously
suggested (0.27 pegs/s) (15). The comprehensive UL assessment
allowed to explore UL dysfunction across neurological disability
stages further. In the mild–moderate disability group, with EDSS
below six, manual dexterity impairments were not associated
with multiple UL dysfunctions as shown by high performances
in UL function, overall UL activity, and use. Similarly, the sEMG
mean level of activation was similar between patients and healthy
subjects, and no significant differences were reported in the
sEMG timing of activation.
Of note, sEMG alterations but not clinical dysfunctions
were evident in patients with EDSS between 6 and 6.5 (severe
ambulant group). The sEMG analysis suggested a progressive
reduction in the modularity of muscular activation pattern
according to increasing neurological disability. Modularity in
muscular activation is defined as the difference between the
maximum and minimum values of muscular activation (16).
This dysfunction could account for the differences in the
timing of maximal activation of the forearm muscles measured
between the severe and the mild–moderate patients during
phase 2 of the movement. In this part of the movement,
patients were holding the cube and moving it to the shelf.
Therefore, extensor carpi muscles were supposed to act as wrist
stabilizers counterbalancing the activation of flexor muscles.
The impairment of this activation timing could contribute to
developing dysfunctional grasping and, as a consequence, manual
dexterity deterioration. This hypothesis is supported by the
significant inverse correlation measured between the NHPT and
patients’ abnormalities in extensor carpi timing of maximal
activation compared to controls. Even in these severely impaired
patients, the sEMGmean level of activation was similar to healthy
subjects. Hence, sEMG data on the amplitude domain suggested
that abnormalities in the timing of activation of distal ULmuscles
rather than the magnitude of UL muscle activation could be
crucial in dexterity deterioration. This impairment could occur
as a consequence of different pathophysiological mechanisms
such as reduction in central drive, reduction in motoneuron
excitability in the spinal cord, or reduction in sarcoplasmic
reticulum calcium uptake in the skeletal muscle. Noteworthy, the
only significant clinical symptom in this group was fatigue.
In the most advanced stages, with EDSS above 6.5, no further
sEMG parameters deterioration were noted in distal segments.
However, proximal shoulder muscles showed a delay in the
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FIGURE 4 | Difference between the timing of maximal activation for functionally coupled muscles.
maximal muscle activation in the eccentric anterior deltoid
contraction during phase 3. These findings were associated
with a UL disuse, impairment in grip task, and an overall
decrease in UL function. Interestingly, the significant increase in
fatigue observed in the previous stage (group 2) was followed
by a significant decrease in the symptom’s severity. A possible
explanation is that the UL disuse was likely to account for
lower perceived fatigue. Fatigue is considered one of the most
disabling symptoms affecting PwMS, leading to the limitation in
UL activities and social participation (37). Both peripheral and
central mechanisms have been described in MS-related fatigue
(38). In the present study, fatigue was assessed using a Numeric
Rating Scale by which patients reported their overall perceived
fatigue during the day while using the UL. This finding might
be influenced by the nature of the assessment used and should
be confirmed using more specific outcome measures of muscle
endurance (i.e., handgrip or static fatigue elbow extension) (15).
So far, positive associations between manual dexterity and
UL deteriorations have been reported by two clinical cross-
sectional studies and one clinical instrumental observational
study (5, 15, 17). The cross-sectional study by Bertoni et al.
(5) explored for the first time UL dysfunctions at different ICF
levels in 105 patients (5). These authors found that patients with
moderate neurological disability (EDSS< 4) showed limitation in
manipulating small objects, while severely affected subjects with
severe hand dexterity impairment showed proximal UL muscles
strength deficit. Lamers et al. (15) found that different levels of
hand dexterity ability based on NHPT accounted for different
associations among outcomemeasures (15). In particular, muscle
strength and active wrist mobility seemed to be more relevant
in patients with severe manual dexterity impairment. Authors
concluded that quantitative analysis of other factors that may
contribute to UL impairment like sensorimotor function, force
control, and fatigue are needed (15). A more recent study by
Pellegrino et al. (17) investigated UL muscle activation pattern
and coordination in different mechanical environments in 11
patients (17). The sEMG analysis showed modifications of
the muscle activation pattern in PwMS compared to healthy
controls during planar reaching movements in PwMS with
mild–moderate UL impairment in Pellegrino et al. (17). In
their study, patients were asked to perform reaching movement
while grasping the handle of a robotic manipulandum. In
contrast with previous findings on stroke patients (39), Pellegrino
et al. (17) found no difference in the number of synergies
involved in the task between patients and healthy controls.
However, proximal muscles like anterior deltoid and biceps
brachii showed different activation pattern compared to controls.
In particular, the authors reported that shoulder muscles had
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different amplitude modulations and increased activity during
the return phase, moving the manipulandum toward their
body while flexing the elbow. Moreover, during the elbow
extension, PwMS coactivated biceps and triceps brachii. Their
findings suggested that the analysis of muscle activation pattern
could improve the understanding of UL impairment in PwMS
representing biomarkers that help in discriminating MS patients
and healthy subjects.
Literature findings are partially consistent with ours. We
did not find a significant association between the NHPT and
Motricity Index, tremor, and sensory loss. One explanation could
be the low level of tremor symptoms and a mild decrease in
sensory loss present in our sample. Interestingly, a positive
association was found between NHPT and UL disuse, suggesting
that behavioral factors could account for severity hand dexterity
impairment of PwMS. In this regard, despite the severe hand
dexterity, the ARAT total score indicates a notable UL capacity
in groups 1 and 2 and limited UL capacity only in group 3. UL
disuse was never explored in the previous cross-sectional studies.
The concept of UL disuse was derived from primary research
with monkeys (6) and then extensively studied in stroke patients
(7). Briefly, injury in the central nervous system (CNS) leads
to sensorimotor deficits and depressed CNS. As a consequence,
the patients experience fewer movements, unsuccessful motor
attempts, and compensatory behavior patterns. PwMS reported
50% less use of both arms as healthy control and overall
lower quality of the movement (8–11). Noteworthy, a reduction
in UL use is closely related to disability and can sustain
maladaptive brain reorganization (1). Specific interventions to
overcome the UL disuse, however, is still under debate in
PwMS (40). In the pilot randomized controlled trial by Mark
et al. (40), 20 adults with hemiparetic MS were randomized
to receive 35 h of either constraint-induced movement therapy
or program of complementary and alternative medicine over
10 consecutive weekdays (40). Changes in the MAL was the
primary outcome measure. Results suggested that constraint-
induced movement therapy might increase real-world use of
the more-affected arm in PwMS, and these effects might last
up to 1 year. Interestingly, the training effects paralleled white
matter changes.
Our findings support the use of sEMG parameters in the
assessment of PwMS. Accordingly, previous work by Pellegrino
et al. (16) concluded that both kinematic and electromyographic
parameters might represent biomarkers that help clinicians
in differentiating patients with different levels of UL motor
impairment from healthy subjects (16). Surface EMG was
reported to help investigate motor dysfunction as force control
and fatigue in PwMS (17, 18). Results are strengthened by
the sEMG protocol used during a task of reaching while
grasping an object. The sEMG assessment has considerable
advantages over other neurophysiological evaluation in the
rehabilitation setting being portable and readily operable with
different tasks (41). Considering the biology-function continuum
for assessment tools in patients with CNS lesions, clinical
scales inform of clinical status, providing mainly functional
insight (41). Conversely, sEMG can provide an aspect of biology
insight (17). Our preliminary analysis was focused on identifying
changes in the modulation and timing of activation to explore
the muscle coordination in functionally coupled muscles like
anterior deltoid and biceps brachii, biceps and triceps brachii,
flexors, and extensors carpi.
The main limitation of our study is the cross-sectional
design that did not allow to track the time course of the
UL deterioration and to follow the real impact of the disease
on the ICF domains. Further prospective longitudinal studies
should consider these limits and introduce the evaluation of
all the clinical and neurophysiological data in a longitudinal
prospective manner along different disease stages. In addition,
the small sample allowed only a preliminary exploration of data
using nonparametric tests for inferential statistic and did not
allow to explore potential gender differences among groups.
Cognitive assessments (i.e., attention, memory, and executive
functions deficits, and mood disorders) and fatigue investigation
to distinguish between central and peripheral components of the
disturbance should be explored in future studies. The strengths
of this study are the use of specific study population and the
attempt to use a multidimensional approach to characterize
UL impairments.
To conclude, the analysis of sEMG data on the amplitude
domain and the association between impairments in body
structure, function, activity, and participation provided new
insight into the understanding of UL disability progression in
PwMS. Manual dexterity should represent a primary target in
PwMS rehabilitation to prevent the development of secondary
UL impairment. The sEMG analysis suggests that impairments
in the forearm muscle activation were associated with
increasing neurological disability and UL deficits at the different
ICF levels.
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